Peptide Therapeutics Market is expected to reach US$ 50,003.15 million by 2027 With Eli Lilly and Company, Amgen Inc., TEVA PHARMACEUTICAL INDUSTRIES LTD, Polypeptide Group, EVER Pharma GmbH, Bristol-Myers Squibb Company, Novo Nordisk A/S, Sanofi, AstraZe

Research Reports

May 11, 2021

According to our new research study on “Peptide Therapeutics Market Forecast to 2027 – COVID-19 Impact and Analysis – by Type, Route of Administration, Synthesis Technology, and Application,” the peptide therapeutics market is expected to reach US$ 50,003.15 million by 2027 from US$ 24,878.55 million in 2019; it is estimated to grow at a CAGR of 9.2% from 2020 to 2027. The report highlights trends prevailing in the market, and the factors driving and hindering the market growth. The growth of the peptide therapeutics market is mainly attributed to the growing investments on peptide therapeutics and increasing prevalence of metabolic disorders and infectious diseases. However, operational limitations of peptides deter the market growth.

To Know How COVID-19 Pandemic Will Impact Global Peptide Therapeutics Market | Get a Sample Copy of Report, Click Here: https://www.theinsightpartners.com/sample/TIPRE00003793/

On the basis of type, the peptide therapeutics market is segmented into innovative and generic. The innovative segment held a larger share of the market in 2019; however, the generic segment is expected to register a higher CAGR during the forecast period. Rising number of research collaborations amongst market players are estimated to offer favorable environment for growth of generic segment.

Increasing utilization of peptide molecules for the development of COVID-19 vaccine is estimated to have a positive impact on the market growth. Moreover, extensive support from government authorities for the use of peptides for COVID-19 vaccine development is also anticipated to offer potential opportunity for the adoption of peptides, which will eventually accelerate the growth of peptide therapeutics market.

Eli Lilly and Company, Amgen Inc., TEVA PHARMACEUTICAL INDUSTRIES LTD, Polypeptide Group, EVER Pharma GmbH, Bristol-Myers Squibb Company, Novo Nordisk A/S, Sanofi, AstraZeneca PLC, and Glaxosmithkline PLC are among the leading companies operating in the peptide therapeutics market.

The report segments peptide therapeutics market as follows:

By Type

Innovative
Generic

By Route of Administration

Parenteral
Mucosal
Oral
Pulmonary
Others

By Synthesis Technology

Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology

By Application

Cancer
Metabolic Disorder
Cardiovascular Disorder
Respiratory Disorder
Pain
Dermatology

By Geography

North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
- Rest of APAC
Middle East and Africa (MEA)
- Saudi Arabia
- UAE
- South Africa
- Rest of MEA
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM

Purchase a copy of the report @ https://www.theinsightpartners.com/buy/TIPRE00003793/

Tags: Peptide Therapeutics Market Type, Peptide Therapeutics Market Analysis Report, Peptide Therapeutics Insight, Peptide Therapeutics Research Reports, Peptide Therapeutics Industry Analysis, Peptide Therapeutics Market Insights, Peptide Therapeutics, , Peptide Therapeutics Market Size, Peptide Therapeutics Market Share, Peptide Therapeutics Market Trends, Peptide Therapeutics Market Analysis, Peptide Therapeutics Market Overview, Peptide Therapeutics Market Outlook, Peptide Therapeutics Market Forecast, Peptide Therapeutics Market See Campaign: https://www.theinsightpartners.com/reports/peptide-therapeutics-market/
Contact Information:
Contact Us Contact Person: Sameer Joshi
Phone: +1-646-491-9876 Email Id:
[email protected]